4
1. 2. 2024.
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više